ScinoPharm Taiwan Ltd Cash Flow Quality Index
ScinoPharm Taiwan Ltd cash flow quality index. ScinoPharm Taiwan Ltd (1789) has a Cash Flow Quality Index of 12.07x as of March 2026. Operating cash flow of NT$199.47 Million exceeds net income of NT$16.53 Million, indicating high earnings quality where cash backs reported profits. Explore 1789 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of ScinoPharm Taiwan Ltd (2007–2025)
Cash flow quality index of ScinoPharm Taiwan Ltd from 2007 to 2025. Historical Cash Flow Quality Index for ScinoPharm Taiwan Ltd across 19 annual periods. Values consistently above 1.0x indicate high-quality earnings. See debt-free asset ratio of ScinoPharm Taiwan Ltd to measure how much of total assets are equity-financed.
ScinoPharm Taiwan Ltd Cash Flow Quality Index by Year (2007–2025)
ScinoPharm Taiwan Ltd cash flow quality index by year from 2007 to 2025. Year-by-year earnings quality comparison for ScinoPharm Taiwan Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of ScinoPharm Taiwan Ltd.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.36x | NT$597.11 Million | NT$136.95 Million | ▲ +139.8% |
| 2024 | 1.82x | NT$750.91 Million | NT$413.02 Million | ▲ +174.4% |
| 2023 | 0.66x | NT$231.13 Million | NT$348.84 Million | ▼ -62.5% |
| 2022 | 1.77x | NT$773.79 Million | NT$437.96 Million | ▲ +4.8% |
| 2021 | 1.69x | NT$509.82 Million | NT$302.29 Million | ▼ -36.1% |
| 2020 | 2.64x | NT$946.31 Million | NT$358.50 Million | ▼ -11.3% |
| 2019 | 2.98x | NT$788.95 Million | NT$265.05 Million | ▲ +18.6% |
| 2018 | 2.51x | NT$1.23 Billion | NT$490.54 Million | ▲ +22.8% |
| 2017 | 2.04x | NT$971.71 Million | NT$475.30 Million | ▼ -0.5% |
| 2016 | 2.05x | NT$1.67 Billion | NT$810.60 Million | ▲ +57.9% |
| 2015 | 1.30x | NT$1.04 Billion | NT$802.88 Million | ▼ -11.8% |
| 2014 | 1.48x | NT$888.29 Million | NT$602.21 Million | ▲ +121.1% |
| 2013 | 0.67x | NT$939.47 Million | NT$1.41 Billion | ▼ -6.8% |
| 2012 | 0.72x | NT$981.55 Million | NT$1.37 Billion | ▼ -46.9% |
| 2011 | 1.35x | NT$1.29 Billion | NT$961.32 Million | ▼ -10.5% |
| 2010 | 1.50x | NT$1.56 Billion | NT$1.04 Billion | ▲ +20.5% |
| 2009 | 1.25x | NT$1.30 Billion | NT$1.04 Billion | ▼ -22.6% |
| 2008 | 1.61x | NT$1.41 Billion | NT$872.11 Million | ▲ +96.2% |
| 2007 | 0.82x | NT$504.50 Million | NT$613.27 Million | — |